Clinical activity of BIBW 2992, an irreversible inhibitor of EGFR/HER2 in adenocarcinoma of the lung with mutations in the kinase domain of HER2neu.

J De Greve, L. Decoster, J. De Mey, Pieter In 'T Veld, Caroline Geers, Martine Taton, Mehdi Shahidi, D. Galdermans, E. Teugels, D Schallier

Onderzoeksoutput: Editorial

30 Citaten (Scopus)
Originele taal-2English
Pagina's (van-tot)90-91
Aantal pagina's2
TijdschriftJournal of Thoracic Oncology
Volume5
StatusPublished - 2010

Citeer dit